Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Peer Review reports

From: Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

Original Submission
30 Nov 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Mar 2022 Reviewed Reviewer Report
29 Apr 2022 Reviewed Reviewer Report
11 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 3
11 Jul 2022 Submitted Manuscript version 3
19 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 4
19 Jul 2022 Submitted Manuscript version 4
28 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 5
28 Jul 2022 Submitted Manuscript version 5
2 Aug 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 6
2 Aug 2022 Submitted Manuscript version 6
18 Aug 2022 Reviewed Reviewer Report
28 Aug 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 7
28 Aug 2022 Submitted Manuscript version 7
14 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
19 Sep 2022 Editorially accepted
29 Sep 2022 Article published 10.1186/s12885-022-10115-3

You can find further information about peer review here.

Back to article page